metabolic · Mechanism Report
Does physiologic stress and inflammation cause low T3 and high reverse T3 by altering deiodinases?
Physiologic stress and inflammatory illness shift thyroid hormone metabolism toward higher reverse T3 and lower active T3 by increasing D3 activity and reducing D1/D2 activity.
This is what AI claimed
Physiologic stress and inflammatory illness can shift thyroid hormone metabolism toward higher reverse T3 and lower T3 (a nonthyroidal illness pattern) by increasing deiodinase 3 activity and reducing deiodinase 1/2 activity.
Executive summary
The claim states that systemic stress/inflammation produces the nonthyroidal illness pattern of low T3 and elevated rT3. The mechanism graph frames this as increased D3-mediated inactivation plus decreased D1/D2-mediated activation, producing reduced T3 production and accumulation of rT3 that further limits T3 bioavailability.
Verified conclusion
Nonthyroidal illness syndrome (NTIS), often referred to as "sick euthyroid syndrome," is a well-documented metabolic adaptation to systemic stress, such as sepsis, trauma, or severe inflammation. This condition is characterized by a specific laboratory profile: low circulating levels of active triiodothyronine (T3) and elevated levels of reverse T3 (rT3), while thyroid-stimulating hormone (TSH) often remains within the normal range or is slightly suppressed.
Mechanistic basis of deiodinase shifting
The transition to an NTIS pattern is driven by the coordinated regulation of deiodinase enzymes, which control the activation and inactivation of thyroid hormones:
- Increased Inactivation (D3): Inflammatory cytokines (such as IL-6 and TNF-alpha) and cortisol upregulate Type 3 deiodinase (D3). D3 is the primary inactivating enzyme; it shunts thyroxine (T4) into inactive rT3 and further degrades active T3 into diiodothyronine (T2). This upregulation is a hallmark of the acute phase response to illness.
- Reduced Activation (D1 and D2): Simultaneously, systemic inflammation suppresses the activity of Type 1 (D1) and Type 2 (D2) deiodinases. D1 and D2 are responsible for the "outer ring" deiodination that converts T4 into active T3. The reduction in these enzymes directly limits the production of the body’s most metabolically active thyroid hormone.
- Bioavailability: The resulting high rT3 levels can further interfere with thyroid function by potentially competing for transport proteins or inhibiting remaining deiodinase activity, compounding the low T3 state.
Clinical significance
Research across diverse patient populations, including those in intensive care and patients with severe COVID-19, shows that the degree of T3 suppression and rT3 elevation correlates strongly with the severity of the underlying illness and mortality risk. While this shift is considered an adaptive mechanism to conserve energy and prevent protein catabolism during acute crisis, persistent NTIS is associated with poorer clinical outcomes and delayed recovery.
Bottom line
The claim is strongly supported by clinical and mechanistic evidence. Physiologic stress and inflammation shift thyroid metabolism toward inactivation by increasing D3 activity and reducing D1/D2 activity, resulting in the characteristic low T3/high rT3 pattern of nonthyroidal illness.
References
- Deiodinases and the Three Types of Thyroid Hormone Deiodination Reactions — pmc.ncbi.nlm.nih.gov
- The Influence of Reverse Triiodothyronine on Neuropsychiatric Disorders: A Narrative Review. — academic.oup.com
- Relationship among Low T3 Levels, Type 3 Deiodinase, Oxidative Stress, and Mortality in Sepsis and Septic Shock: Defining Patient Outcomes — mdpi.com
- Critical illness-implications of non-thyroidal illness syndrome and thyroxine therapy — wjgnet.com
- Nonthyroidal Illness Syndrome Across the Ages — academic.oup.com
- New Insights toward the Acute Non-Thyroidal Illness Syndrome — pmc.ncbi.nlm.nih.gov
- Study of Thyroid Functions in critically ill Patients admitted in Medical Intensive Care Unit and its Correlation with Critical Care Scoring Acute Physiology and Chronic Health Evaluation III. — japi.org
- An update on non-thyroidal illness syndrome — pmc.ncbi.nlm.nih.gov
- Thyroid function in critically ill patients. — pmc.ncbi.nlm.nih.gov
- IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. — pmc.ncbi.nlm.nih.gov
- Regulation of Hepatocyte Thyroxine 5′-Deiodinase by T3 and Nuclear Receptor Coactivators as a Model of the Sick Euthyroid Syndrome* — jbc.org
- Oxidative remote induction of type 3 deiodinase impacts nonthyroidal illness syndrome. — joe.bioscientifica.com
See a full patient report verified like this
Book a walkthrough